Compare O'Reilly Automotive Inc. Common Stock (ORLY) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
O'Reilly Automotive Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? O'Reilly Automotive Inc. Common Stock trades at $85.87 (market cap $69.58B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.74B). The key difference: O'Reilly Automotive Inc. Common Stock is the larger of the two by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while O'Reilly Automotive Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ORLY | TAK | |
|---|---|---|
Market Cap | $69.58B | $58.74B |
Volume | 4,819,072 | 3,110,994 |
Sector | Consumer Cyclical | Health |
52-Week High | $103.05 | $19.05 |
52-Week Low | $82.73 | $13.23 |
Enterprise Value | $78.90B | $86.65B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 3.33% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About O'Reilly Automotive Inc. Common Stock
O'Reilly Automotive sells automotive aftermarket parts, tools, supplies, equipment, and accessories. It serves both professional service providers and do-it-yourself customers through its store network.
Read more on ORLY →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
